| 产品名称： | Brevibacillus laterosporus (Laubach) Shida et al. |
|---|---|
| 商品货号： | TS165324 |
| Deposited As： | Bacillus laterosporus Laubach |
| Strain Designations： | BMG162-aF2 FERM-P 5230 |
| Application： | Produces BMG162-aF2 |
| Isolation： | Soil, Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Inst. Microb. Chem. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| References： | Takeuchi T, et al. Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient. US Patent 4,416,899 dated Nov 22 1983 Umezawa H, et al. Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said antibiotic as active ingredient. US Patent 4,474,880 dated Oct 2 1984 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Brevibacillus laterosporus (Laubach) Shida et al. |
|---|---|
| 商品货号： | TS165324 |
| Deposited As： | Bacillus laterosporus Laubach |
| Strain Designations： | BMG162-aF2 FERM-P 5230 |
| Application： | Produces BMG162-aF2 |
| Isolation： | Soil, Japan |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 3: Nutrient agar or nutrient broth |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Inst. Microb. Chem. |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| References： | Takeuchi T, et al. Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient. US Patent 4,416,899 dated Nov 22 1983 Umezawa H, et al. Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said antibiotic as active ingredient. US Patent 4,474,880 dated Oct 2 1984 |
